Montreal, Canada · Founded 2008 · Privately Held (backing)
Developer of cold plasma delivery system designed to reduce cancer recurrence. NexPlasmaGen is based in Montreal, Canada and was founded in 2008. Its last reported valuation was $6.6 million in Dec 2024. It has raised $960,000.
Last reported valuation
$6.6M
Oct 2026
Priced at
—
Total raised
$960K
Last round
—
Team — not yet on record
No current team members for NexPlasmaGen are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NexPlasmaGen with a free account
·The complete investor list: 25 names
·Watch NexPlasmaGen: the Monday email on marks, rounds and moves
